한글목차

바이오소재 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 1,514억 7,000만 달러에서 2026년에는 1,725억 4,000만 달러로, CAGR 13.9%로 성장할 것으로 예상됩니다. 지난 몇 년간의 성장은 정형외과 및 치과 임플란트 수술의 증가, 심혈관질환의 유병률 증가, 의료 인프라의 발전, 고분자 및 금속 가공 기술의 발전, 의료용 임플란트의 보급 확대에 기인하는 것으로 보입니다.

바이오소재 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 2,844억 4,000만 달러에 달하고, CAGR은 13.3%를 기록할 전망입니다. 예측 기간의 성장 요인으로는 전 세계 고령화, 재생의료 수요 증가, 생체재료 3D 프린팅 기술 발전, 생물의학 연구 투자 확대, 신경질환 치료 및 상처 치유 치료의 적용 범위 확대 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 생체적합성 및 생체활성 재료에 대한 수요 증가, 생분해성 생체 재료의 채택 확대, 조직 공학에서 생체 재료의 사용 증가, 첨단 이식형 의료기기의 보급 확대, 환자 맞춤형 생체 재료에 대한 관심 증가 등을 들 수 있습니다. 등을 꼽을 수 있습니다.

의료비 지출 증가는 바이오소재 시장의 성장을 견인할 것으로 예상됩니다. 의료비 지출은 특정 기간(보통 국가 또는 기관 수준)에 의료 서비스, 치료, 의료 인프라에 할당된 총 자금을 의미합니다. 이 지출의 일부는 생체재료의 연구개발, 조달, 도입, 규제 준수에 사용됩니다. 예를 들어, 미국 의사협회(AMA)의 보고서에 따르면 2023년 미국이 의료에 지출한 총액은 4조 8,665억 달러(1인당 1만 4,570달러)에 달합니다. 이는 전년 대비 7.5% 증가한 것으로, 2022년 4.6% 증가에서 큰 폭의 성장세를 보이고 있습니다. 의료비 증가에 따라 바이오소재 시장의 성장이 촉진될 것으로 예상됩니다.

바이오소재 시장에서 사업을 전개하는 주요 기업들은 지속가능한 바이오폴리머를 제공하고 경쟁 우위를 확보하기 위해 설계 효소 바이오소재(DEB) 기술 플랫폼과 같은 기술 혁신에 집중하고 있습니다. 효소 기반 바이오소재(DEB) 기술 플랫폼은 효소를 이용하여 물질을 설계 및 개질하고, 약물전달, 조직공학, 진단 등 다양한 용도로 응용하는 기술입니다. 예를 들어, 2023년 6월, 미국에 본사를 둔 향료, 향료 및 화장품 활성 성분 제조업체인 International Flavors and Fragrances는 바이오 기반 소재의 대규모 개발을 위한 효소 기반 바이오소재 기술 플랫폼을 발표했습니다. 화석 유래 소재와 동등하거나 그 이상의 성능을 제공하면서도 실질적인 지속가능성의 이점을 제공하도록 설계된 DEB 기술은 친환경적이고 고성능의 바이오폴리머에 대한 수요 증가에 대응할 수 있습니다. 이 기술 플랫폼을 통해 생산자는 기존의 화석 유래 합성 폴리머를 대체하여 규제 변화에 대응하고 소비자 수요 증가에 대응할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

The biomaterials refer to manmade substances that can be utilized to support tissues or structures in the body. These are natural or synthetic materials that are used in medical applications to support, enhance, or replace damaged tissue or a biological function.

The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterials are stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues. The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs on specialty metals, polymers, and ceramic materials have impacted the biomaterials market by increasing raw material and manufacturing costs, particularly for metallic and polymeric biomaterials used in implants and medical devices. Regions such as North America, Europe, and Asia-Pacific are most affected due to their dependence on global supply chains for titanium alloys, polymers, and bioceramics. While tariffs have created cost pressures and pricing challenges, they have also encouraged local manufacturing, material innovation, and supply chain diversification, supporting long-term resilience in the biomaterials industry.

The biomaterials market research report is one of a series of new reports from The Business Research Company that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomaterials market size has grown rapidly in recent years. It will grow from $151.47 billion in 2025 to $172.54 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to growth in orthopedic and dental implant procedures, rising prevalence of cardiovascular diseases, increased healthcare infrastructure development, advancements in polymer and metal processing technologies, growing adoption of medical implants.

The biomaterials market size is expected to see rapid growth in the next few years. It will grow to $284.44 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to aging global population, increasing demand for regenerative medicine, advancements in 3d printing of biomaterials, rising investment in biomedical research, expanding applications in neurological and wound healing treatments. Major trends in the forecast period include rising demand for biocompatible and bioactive materials, growing adoption of biodegradable biomaterials, increasing use of biomaterials in tissue engineering, expansion of advanced implantable medical devices, rising focus on customized and patient-specific biomaterials.

The rising healthcare spending is expected to drive the growth of the biomaterials market. Healthcare spending refers to the total financial resources allocated for medical services, treatments, and healthcare infrastructure over a specific period, typically at a national or institutional level. A portion of this spending is directed toward the research, development, procurement, adoption, and regulatory compliance of biomaterials. For example, in 2025, according to the American Medical Association (AMA), a U.S.-based professional association, the United States spent a total of $4,866.5 billion, or $14,570 per capita, on healthcare in 2023. This represents a 7.5% increase from the previous year, reflecting a significant rise compared to the 4.6% growth seen in 2022. As healthcare spending increases, it will contribute to the growth of the biomaterials market.

Major companies operating in the biomaterials market focus on technological advancements, such as the designed enzymatic biomaterials (DEB) technology platform, to deliver sustainable biopolymers and gain a competitive advantage. The enzymatic biomaterials (DEB) technology platform involves the use of enzymes to design and modify materials for various applications, including drug delivery, tissue engineering, and diagnostics. For instance, in June 2023, International Flavors & Fragrances Inc., a US-based producer of flavors, fragrances, and cosmetic actives, launched the enzymatic biomaterials technology platform for the development of biobased materials at scale. Designed to deliver meaningful sustainability benefits with performance comparable to or superior to fossil-based materials, DEB technology helps to address growing preferences for environmentally friendly, high-performance biopolymers. The technology platform allows producers to fulfill regulatory changes and increasing consumer demand by replacing traditional fossil-based synthetic polymers.

In October 2024, RTI Surgical (RTI), a US-based medical equipment manufacturing company, acquired Collagen Solutions plc for an undisclosed amount. The objective of RTI Surgical's acquisition of Collagen Solutions is to broaden its soft tissue portfolio and improve its capabilities in the regenerative medicine sector. Collagen Solutions plc is a US-based supplier, developer, and manufacturer of medical-grade collagen, tissues, and other biomaterials for use in regenerative medicine, medical devices, and research.

Major companies operating in the biomaterials market report are Corbion N V, Evonik Industries AG, Heraeus Medical Components LLC, Berkeley Advanced Biomaterials Inc., Zimmer Biomet Holdings Inc., DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG, Kyocera Corporation, Wright Medical Group NV, KLS Martin Group GmbH & Co KG, Meccellis Biotechnology Co Ltd., Bio-on SpA, Coloplast A/S, Collagen Matrix Inc., IntrinsiQ Materials Inc., PolyActiva Pty Ltd

North America was the largest region in the biomaterials market in 2025. The regions covered in the biomaterials market are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biomaterials market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biomaterials market consists of sales of metals, polymers, and composites. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomaterials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Metallic Biomaterial; Polymeric Biomaterials; Natural Biomaterials; Ceramics
• 2) By Application: Cardiovascular; Orthopedic; Ophthalmology; Dental; Plastic Surgery; Wound Healing; Tissue Engineering; Neurological/Central Nervous System
• 3) By End Use: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Metallic Biomaterials: Stainless Steel; Titanium Alloys; Cobalt-Chromium Alloys; Magnesium Alloys
• 2) By Polymeric Biomaterials: Synthetic Polymers; Natural Polymers; Biodegradable Polymers
• 3) By Natural Biomaterials: Animal-Derived Materials; Plant-Derived Materials
• 4) By Ceramics: Bioceramics; Porous Ceramics; Non-porous Ceramics
• Companies Mentioned: Corbion N V; Evonik Industries AG; Heraeus Medical Components LLC; Berkeley Advanced Biomaterials Inc.; Zimmer Biomet Holdings Inc.; DSM Biomedical BV; PolyNovo Limited; Baxter International Inc.; Stryker Corporation; Collagen Solutions plc; Invibio Ltd.; Aap Implantate AG; Cam Bioceramics BV; CeramTec GmbH; CoorsTek Medical LLC; CryoLife Inc.; Cerapedics Inc.; Surmodics Inc.; Secant Group LLC; GELITA AG; Kyocera Corporation; Wright Medical Group NV; KLS Martin Group GmbH & Co KG; Meccellis Biotechnology Co Ltd.; Bio-on SpA; Coloplast A/S; Collagen Matrix Inc.; IntrinsiQ Materials Inc.; PolyActiva Pty Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Biomaterials Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Biomaterials Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Biomaterials Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Biomaterials Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Sustainability, Climate Tech & Circular Economy
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Biocompatible And Bioactive Materials
  • 4.2.2 Growing Adoption Of Biodegradable Biomaterials
  • 4.2.3 Increasing Use Of Biomaterials In Tissue Engineering
  • 4.2.4 Expansion Of Advanced Implantable Medical Devices
  • 4.2.5 Rising Focus On Customized And Patient-Specific Biomaterials

5. Biomaterials Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Ambulatory Surgical Centers
• 5.4 Specialty Medical Centers
• 5.5 Research And Academic Institutes

6. Biomaterials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biomaterials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Biomaterials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Biomaterials Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Biomaterials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Biomaterials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biomaterials Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biomaterials Market Segmentation

• 9.1. Global Biomaterials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Metallic Biomaterial, Polymeric Biomaterials, Natural Biomaterials, Ceramics
• 9.2. Global Biomaterials Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System
• 9.3. Global Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users
• 9.4. Global Biomaterials Market, Sub-Segmentation Of Metallic Biomaterials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Stainless Steel, Titanium Alloys, Cobalt-Chromium Alloys, Magnesium Alloys
• 9.5. Global Biomaterials Market, Sub-Segmentation Of Polymeric Biomaterials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Synthetic Polymers, Natural Polymers, Biodegradable Polymers
• 9.6. Global Biomaterials Market, Sub-Segmentation Of Natural Biomaterials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Animal-Derived Materials, Plant-Derived Materials
• 9.7. Global Biomaterials Market, Sub-Segmentation Of Ceramics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bioceramics, Porous Ceramics, Non-porous Ceramics

10. Biomaterials Market Regional And Country Analysis

• 10.1. Global Biomaterials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Biomaterials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biomaterials Market

• 11.1. Asia-Pacific Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biomaterials Market

• 12.1. China Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biomaterials Market

• 13.1. India Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biomaterials Market

• 14.1. Japan Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biomaterials Market

• 15.1. Australia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biomaterials Market

• 16.1. Indonesia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biomaterials Market

• 17.1. South Korea Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biomaterials Market

• 18.1. Taiwan Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biomaterials Market

• 19.1. South East Asia Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biomaterials Market

• 20.1. Western Europe Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biomaterials Market

• 21.1. UK Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biomaterials Market

• 22.1. Germany Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biomaterials Market

• 23.1. France Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biomaterials Market

• 24.1. Italy Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biomaterials Market

• 25.1. Spain Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biomaterials Market

• 26.1. Eastern Europe Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biomaterials Market

• 27.1. Russia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biomaterials Market

• 28.1. North America Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biomaterials Market

• 29.1. USA Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biomaterials Market

• 30.1. Canada Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biomaterials Market

• 31.1. South America Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biomaterials Market

• 32.1. Brazil Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biomaterials Market

• 33.1. Middle East Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biomaterials Market

• 34.1. Africa Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biomaterials Market Regulatory and Investment Landscape

36. Biomaterials Market Competitive Landscape And Company Profiles

• 36.1. Biomaterials Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Biomaterials Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Biomaterials Market Company Profiles
  • 36.3.1. Corbion N V Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Heraeus Medical Components LLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Berkeley Advanced Biomaterials Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Biomaterials Market Other Major And Innovative Companies

• DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG

38. Global Biomaterials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biomaterials Market

40. Biomaterials Market High Potential Countries, Segments and Strategies

• 40.1 Biomaterials Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Biomaterials Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Biomaterials Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer